The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II randomized, double-blind, placebo-controlled study to evaluate naldemedine for the treatment of opioid-induced constipation (OIC) in patients with cancer pain.
 
Narikazu Boku
Honoraria - Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Shionogi
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Nobuyuki Katakami
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Dainippon Sumitomo Pharma; Janssen; Lilly; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
 
Shiro Fujita
Research Funding - Chugai Pharma; Ono Pharmaceutical
 
Koji Oda
No Relationships to Disclose
 
Katsunori Tauchi
No Relationships to Disclose
 
Ken Nakata
Honoraria - Bayer; Bristol-Myers Squibb; Takeda
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Takeda
 
Katsunori Shinozaki
Honoraria - Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Ono Pharmaceutical; Otsuka; Shionogi; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
 
Motoyasu Okuno
Honoraria - Ono Pharmaceutical
Research Funding - Daiichi Sankyo (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Yasukazu Kawai
No Relationships to Disclose
 
Hiroaki Kikukawa
Honoraria - Shionogi
 
Ryujiro Suzuki
Honoraria - Shionogi
 
Hideo Nakazawa
Stock and Other Ownership Interests - Daiichi Sankyo; Eisai; Shionogi
Honoraria - Shionogi
 
Hiroshi Kojima
Honoraria - Shionogi
 
Mitsuhiro Mizutani
No Relationships to Disclose
 
Toru Hara
Honoraria - Kyorin
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Takaaki Yokota
Employment - Shionogi
Stock and Other Ownership Interests - Shionogi
Research Funding - Shionogi
 
Yura Suzuki
Employment - Shionogi
Stock and Other Ownership Interests - Shionogi
 
Masaru Narabayashi
Honoraria - Chugai Pharma
Consulting or Advisory Role - Shionogi